Globe Life (NYSE:GL – Get Free Report) had its target price boosted by equities researchers at Truist Financial from $158.00 to $180.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 22.05% from the company’s previous close.
Several other analysts have also recently commented on GL. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday. Piper Sandler reissued an “overweight” rating and set a $167.00 target price on shares of Globe Life in a report on Friday, November 21st. Wells Fargo & Company decreased their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. TD Cowen restated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Finally, Evercore ISI cut Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price target on the stock. in a research report on Tuesday, January 6th. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $171.00.
Read Our Latest Stock Report on Globe Life
Globe Life Trading Up 0.4%
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm earned $3.14 EPS. The company’s revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Research analysts forecast that Globe Life will post 13.87 EPS for the current year.
Insider Buying and Selling
In other news, CEO Frank M. Svoboda sold 9,379 shares of the business’s stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,036,943.24. The trade was a 20.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.51% of the company’s stock.
Institutional Trading of Globe Life
A number of institutional investors have recently modified their holdings of GL. Norges Bank purchased a new position in Globe Life during the 2nd quarter valued at about $157,722,000. Northwestern Mutual Wealth Management Co. raised its holdings in Globe Life by 34,786.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after purchasing an additional 879,391 shares in the last quarter. AQR Capital Management LLC lifted its position in Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after acquiring an additional 696,548 shares during the period. Balyasny Asset Management L.P. bought a new stake in Globe Life during the third quarter worth about $80,925,000. Finally, Leith Wheeler Investment Counsel Ltd. increased its position in Globe Life by 615.9% during the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 656,807 shares of the company’s stock valued at $81,635,000 after buying an additional 565,061 shares in the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Nervous about the stock market? Read this
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
